Below are the most recent publications written about "Retinoblastoma" by people in Profiles.
-
Shields CL, Medina R, Evans H, Valdes-Perez N, Acar AB, Bansal R, Lally SE, Shields JA. HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA, SUBRETINAL SEEDS, AND VITREOUS SEEDS. Retina. 2025 01 01; 45(1):1-6.
-
Silverman RF, Francis JH, Robbins MA, Dunkel IJ, Abramson DH. RB1 CIRCULATING TUMOR DNA IN THE BLOOD OF PATIENTS WITH RETINOBLASTOMA INCREASES IN UNTREATED PATIENTS. Retina. 2024 12 01; 44(12):2123-2128.
-
Kaliki S, Vempuluru VS, Bakal KR, Dorji S, Tanna V, Shields CN, Fallon SJ, Raval V, Ahmad A, Mushtaq A, Hussain M, Yousef YA, Mohammad M, Roy SR, Huque F, Tatiana U, Yuri S, Vladimir P, Zambrano SC, Alarc?n-Le?n S, Valdiviezo-Zapata C, Vargas-Martorellet M, Gutierrez-Chira C, Buitrago M, Ortiz JS, Diaz-Coronado R, Tripathy D, Rath S, Patil G, Berry JL, Pike S, Brown B, Tanabe M, Frenkel S, Eiger-Moscovich M, Pe'er J, Shields CL, Eagle RC, Laiton A, Velasco AM, Vega K, DeSimone J, Bejjanki KM, Kapoor AG, Venkataraman A, Bryant V, Reddy MA, Sagoo MS, Hubbard GB, Azarcon CP, Olson TA, Grossniklaus H, Rolfe O, Staffieri SE, O'Day R, Mathew AA, Elder JE, McKenzie JD, Fabian ID, Shemesh R, Vishnevskia-Dai V, Ali MH, Jakati S, Mishra DK, Palkonda VAR. HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents. Retina. 2024 12 01; 44(12):2105-2115.
-
Arazi M, Baum A, Casavilca-Zambrano S, Alarcon-Leon S, Diaz-Coronado R, Ahmad A, Mushtaq A, Hussain M, Ushakova T, Yuri S, Vladimir P, Shields CL, Eagle RC, Berry JL, Pike S, Brown B, Roy SR, Huque F, Fabian I, Frenkel S, Eiger-Moscovich M, Pe'er J, Hubbard GB, Olson TA, Grossniklaus H, Reddy MA, Sagoo MS, Staffieri SE, Elder JE, McKenzie JD, Tanabe M, Kaliki S, Fabian ID. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. Am J Ophthalmol. 2024 Dec; 268:399-408.
-
Pascual-Pasto G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, Hofmann TJ, Burgue?o V, Harvey K, Martinez D, Shah AC, Foster JB, Pogoriler J, Eagle RC, Carcaboso AM, Shields CL, Leahey AM, Bosse KR. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clin Cancer Res. 2024 Aug 15; 30(16):3578-3591.
-
Dockery PW, Ruben M, Duffner ER, Levin HJ, Lally SE, Shields JA, Shields CL. Likelihood of germline mutation with solitary retinoblastoma based on tumour location at presentation. Br J Ophthalmol. 2023 12 18; 108(1):131-136.
-
Shields CL, Bas Z, Laiton A, Silva AMV, Sheikh A, Lally SE, Shields JA. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2023 04; 37(5):815-822.
-
Kaliki S, Shields CL, Cassoux N, Munier FL, Chantada G, Grossniklaus HE, Yoshikawa H, Fabian ID, Berry JL, McKenzie JD, Kimani K, Reddy MA, Parulekar M, Tanabe M, Furuta M, Grigorovski N, Chevez-Barrios P, Scanlan P, Eagle RC, Rashid R, Coronado RD, Sultana S, Staffieri S, Frenkel S, Suzuki S, Ushakova TL, Ji X. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2022 Jan 01; 140(1):30-36.
-
Mandigo AC, Tomlins SA, Kelly WK, Knudsen KE. Relevance of pRB Loss in Human Malignancies. Clin Cancer Res. 2022 01 15; 28(2):255-264.
-
Khodabande A, Ghassemi F, Asadi Amoli F, Riazi-Esfahani H, Mahmoudzadeh R, Mehrpour M, Valipour N. Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits. Pharmacol Res Perspect. 2021 08; 9(4):e00814.